|
Prescribing
Information for BIPI Marketed Products |
|
|||||
|
Product Name |
Version |
Current Prescribing Information |
|
|||
|
|
||||||
|
Aggrenox®
Capsules
|
December 2019 |
|||||
|
Aptivus®
Capsules and Oral Solution |
November 2019 |
|||||
|
Atrovent®
HFA Inhalation Aerosol |
February
2020 IT7036C |
|||||
|
Catapres®
Tablets |
August 2016 |
|||||
|
Catapres-TTS®
Transdermal Therapeutic System |
August 2016 |
|
||||
|
Combivent® Respimat® |
June 2016 |
|
||||
|
Gilotrif®
Tablets |
October 2019 |
|
||||
|
Glyxambi®
Tablets |
March
2020 IT5885S |
|
||||
|
Jardiance® Tablets (empagliflozin) |
January 2020 IT5728V |
|
||||
|
Jentadueto®
Tablets |
March
2020 IT6841I |
|
|
|||
|
Jentadueto®
XR extended-release tablets |
March
2020 IT6354H |
|
||||
|
Micardis®
HCT Tablets
|
February 2018 |
|
||||
|
Micardis®
Tablets
|
February 2018 |
|
||||
|
Mirapex®
Tablets
|
January 2020 |
|
||||
|
Mirapex ER®
extended-release tablets
|
January 2020 |
|
|
|||
|
Mobic®
Tablets
|
February 2020 |
|
||||
|
Ofev®
Capsules |
March 2020 |
|
||||
|
Persantine
Tablets |
December 2019 |
|
||||
|
Pradaxa® Capsules (dabigatran
etexilate mesylate) |
November 2019 |
|
||||
|
Praxbind®
Injection |
April 2018 IT6116B |
|
||||
|
Spiriva® |
February 2018 |
|
||||
|
Spiriva® Respimat® |
March 2019 |
|
||||
|
Stiolto®
Respimat® |
May 2019 |
|
||||
|
Striverdi®
Respimat® |
May 2019 |
|
||||
|
Synjardy®
Tablets |
January 2020 |
|
||||
|
Synjardy®
XR extended-release Tablets |
January 2020 |
|
||||
|
Tradjenta®
Tablets (linagliptin) |
March 2020 |
|
||||
|
Trijardy™
XR Tablets (empagliflozin, linagliptin, and metformin
hydrochloride extended-release) |
January 2020 |
|
||||
|
Twynsta® Tablets |
February 2018 |
|
|
|||
|
Viramune®
Tablets and Oral Suspension |
October 2019 |
|
||||
|
Viramune XR®Tablets (nevirapine) |
October 2019 IT5243N |
|
||||
|
|
|
|
|
|||
|
|
||||||